Director's Dealing

RNS Number : 3090Y

Omega Diagnostics Group PLC

28 November 2014

 



OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Director's Dealing

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Andrew Shepherd, Chief Executive Officer of the Company, today purchased 30,974 ordinary shares in the Company at 17p per share through his SIPP.

Following this transaction, Mr Shepherd's total beneficial holding has increased to 2,677,206 ordinary shares representing 2.5 per cent of the issued ordinary share capital of the Company.

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone] or www.omegadiagnostics.com
Andrew Shepherd, Chief Executive
Kieron Harbinson, Group Finance Director     Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Christopher Raggett (Corporate Finance) Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

RDSPGGPWGUPCGUR